Superior mesenteric artery (SMA) syndrome is a rare condition that must be differentiated from other gastrointestinal diseases manifesting as upper abdominal pain, nausea, or vomiting. The description of SMA syndrome is compression of the third portion of the duodenum by the SMA and the abdominal aorta. SMA syndrome is managed with nasoenteral nutrition or surgical strategies such as laparoscopic duodenojejunostomy. However, SMA syndrome treated using enteral nutrition by percutaneous radiologic gastrojejunostomy has not been reported. Here, we report our experience of successfully managing a case of SMA syndrome with percutaneous radiologic gastrojejunostomy. (Korean J Gastroenterol 2016;67:321-326) 
INTRODUCTION
Superior mesenteric artery (SMA) syndrome, also known as Wilkie's syndrome, is an uncommon, benign cause of duodenal obstruction by compression of the third portion of the duodenum due to narrowing of the angle between the SMA and the abdominal aorta. SMA syndrome manifests as nonspecific obstructive symptoms of nausea, vomiting, epigastric pain, and abdominal distension. Anorexia and weight loss can occur in chronic cases. SMA syndrome can result in significant electrolyte imbalances, dehydration, and malnutrition. In addition, recurrent vomiting may lead to aspiration pneumonia. Due to the life-threatening nature of some of these problems, prompt diagnosis and treatment are necessary. SMA syndrome is managed with total parenteral nutrition (TPN), nasojejunal enteral feeding, or surgical strategies such as laparoscopic duodenojejunostomy. 1 To the best of our knowledge, there are no reports of enteral nutrition by percutaneous radiologic gastrojejunostomy (PRGJ) being used to treat SMA syndrome. Here, we describe a case of SMA syndrome successfully managed with PRGJ.
CASE REPORT
A 72-year-old woman who was bed-ridden for 20 years after deep brain stimulation for Parkinson's disease presented at the emergency room complaining of abdominal distension and vomiting for three days. On admission, she was hypo-
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The Korean Journal of Gastroenterology We inserted a nasogastric tube to decompress the stomach, then drained 2.5 L of gastric contents. After five days of conservative treatment using nil per os and nasogastric drainage, an additional nasojejunal tube was inserted to commence enteral nutrition ( for simultaneous feeding via the jejunum and aspiration of the gastric content of the stomach (Fig. 4) . We performed the 
The The treatment of SMA syndrome is aimed at managing the precipitating factor, which is usually related to weight loss.
Loss of intra-abdominal fat (mesenteric fat) around the SMA will decrease the aortomesenteric angle and the distance between the SMA, and the aorta causes mechanical compression of the duodenum. 8 Therefore, conservative treatment with nasogastric decompression and nutritional supplementation to facilitate weight gain and resolve electrolyte imbalances and dehydration are attempted before surgical bypass, which is reserved for those who do not respond to medical treatment. Nasoenteral or nasogastric tube feeding has been widely and safely used to provide adequate nutrition in patients who are prohibited from ingesting food and fluids until the obstructive lesion resolves or their enteral function returns. 9,10 A retrospective study reported that the overall success rate of medical treatment for SMA syndrome was 71.3% (57 of 80 patients) during a median observation period of five months (range, 1-84 months), while the recurrence rate was 15.8% (9 of 57 patients). 7 Another retrospective study showed a success rate for initial nasojejunal tube placement of 91.5% and a tube-related late complication rate of 23% in patients without SMA syndrome.
11
However, the success rate of nasoenteral treatment in SMA syndrome patients was not evaluated, because most studies did not divide the medical treatment group into subgroups, such as TPN and nasoenteral groups.
As mentioned above, nasojejunal tubes are safe, but they can be uncomfortable and easily dislodged. 11 In addition, the long-term use of nasoenteral tubes is associated with several problems such as tube blockage, gastroesophageal reflux, and tracheoesophageal fistula. 12 Other possible complications due to feeding tube misplacement include pneumothorax, intrapleural infusion of the enteral diet, esophageal perforation, and necrosis of the nasal ala. 12, 13 While the nasoenteral tube is acceptable when enteral nutrition is indicated for one month or less, for more prolonged nutritional replacement experts recommend percutaneous or surgical enterostomy.
14 Laparoscopic duodenojejunostomy is the surgical treatment of choice if conservative management fails, and is successful in up to 90-100% of cases. 1, 7 However, patients with serious comorbidities are at increased risk of postoperative complications such as pneumonia, confusion, stroke, myocardial infarction, and acute kidney injury. These comorbidities include old age, malnutrition, chronic obstructive pulmonary disease, advanced liver cirrhosis, heart failure, and ischemic heart disease. [15] [16] [17] [18] Long-term medical treatment should be considered in these high-risk patients instead of surgical options.
PRG, also known as transgastric jejunostomy, is performed for nutritional support or gastrointestinal decompression as percutaneous gastrostomy with the benefit of reducing gastroesophageal reflux or aspiration. 19 Primary percutaneous gastrojejunostomy is a procedure in which a tube tip is placed into the jejunum through a puncture site in the stomach wall. As with PRG, major complications include peri- for surgery) and 30-days procedure-related mortality rates were highest for surgery (2.5% vs. 0.3% for radiologic gastrostomy and 0.53% for PEG) in a meta-analysis. 24 However, no comparative studies of PRGJ and laparoscopic duodenojejunostomy are available.
Combined gastrostomy and gastrojejunostomy tubes can be used for simultaneous enteral feeding and gastric drainage with a decreased risk of aspiration. 25 Double-lumen gastrojejunostomy tubes have been used for simultaneous enteral feeding and gastric decompression. 26, 27 These tubes may be particularly useful in patients with SMA syndrome. Long-term gastric decompression is accomplished by continuous or intermittent drainage through the aspiration (gastric) port without nasopharyngeal discomfort and complications associated with prolonged nasal intubation. Because feeding through gastrostomy is unavailable until the duodenal obstruction has resolved, nutritional support can be maintained through the feeding (jejunal) port.
The patient in this report was at high risk for surgical complications due to her advanced age and history of being bed-ridden due to a neurological disease. The patient's condition improved with long-term nutritional therapy by PRGJ using a double-lumen gastrojejunostomy tube to avoid the risks of surgical intervention under general anesthesia.
In conclusion, PRGJ can be a feasible alternative medical option in high-risk patients with chronic SMA who have comorbidities that make them unsuitable for surgical management. Further case reports are needed to allow high-quality comparisons of the available treatment modalities for SMA syndrome.
